Literature DB >> 8625002

Signposts to therapy: recent advances in inflammatory bowel disease research.

J Hamilton.   

Abstract

Research on ulcerative colitis and Crohn disease, the two conditions grouped under the heading of inflammatory bowel disease (IBD), is improving our understanding of how the intestine functions at the cellular level in health and disease. Researchers in the McGill Inflammatory Bowel Disease Research Program are studying the factors that affect the transport of nutrients, salt and water across cell membranes in the intestinal epithelium and investigating the cellular mechanisms of diarrhea. Their main interest is in how the intestine adapts in response to inflammation. Their findings promise to yield new targets for the pharmacologic and dietary management of IBD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625002      PMCID: PMC1487827     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

2.  Na(+)-K(+)-ATPase alpha 1- and beta 1-mRNA and protein levels in rat small intestine in experimental ileitis.

Authors:  G E Wild; A B Thomson
Journal:  Am J Physiol       Date:  1995-11

3.  Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.

Authors:  B G Feagan; J W McDonald; J Rochon; A Laupacis; R N Fedorak; D Kinnear; F Saibil; A Groll; A Archambault; R Gillies
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

4.  Effect of exogenously administered polyamine on the structural maturation and enzyme ontogeny of the postnatal rat intestine.

Authors:  G E Wild; A S Daly; N Sauriol; G Bennett
Journal:  Biol Neonate       Date:  1993

5.  Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.

Authors:  B G Feagan; J Rochon; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; R Gillies; M Hopkins
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

6.  Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease.

Authors:  H Allgayer; W Kruis; G Paumgartner; B Wiebecke; L Brown; E Erdmann
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

7.  Alterations in quantitative distribution of Na,K-ATPase activity along crypt-villus axis in animal model of malabsorption characterized by hyperproliferative crypt cytokinetics.

Authors:  G E Wild; D Murray
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

8.  Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.

Authors:  G R Greenberg; B G Feagan; F Martin; L R Sutherland; A B Thomson; C N Williams; L G Nilsson; T Persson
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.